SOPs for BA-BE Studies V 2.0

To establish uniform gowning procedures for all clinical staff entering controlled and semi-controlled areas during the conduct of BA/BE studies to minimize contamination risk and maintain hygiene standards as per regulatory requirements.
Click to read the full article.

To establish a standardized procedure for receiving and logging Clinical Trial Material (CTM) used in BA/BE studies, ensuring traceability, accountability, and compliance with GCP and regulatory requirements.
Click to read the full article.

To define a standardized procedure for managing and maintaining calibration logs of equipment used in bioavailability/bioequivalence (BA/BE) studies, ensuring all trial equipment is calibrated, traceable, and fit for intended use throughout the study period.
Click to read the full article.

To define a clear and effective procedure for the activation and management of emergency protocols during the conduct of BA/BE studies in order to ensure immediate response, subject safety, and adherence to regulatory obligations.
Click to read the full article.

To establish a uniform procedure for the review and approval of clinical supply labels for investigational and comparator products used in bioavailability/bioequivalence (BA/BE) studies, ensuring compliance with regulatory guidelines and trial protocols.
Click to read the full article.

To define the procedure for maintaining and using the Emergency Medical Resuscitation Kit at clinical sites conducting BA/BE studies in order to ensure immediate availability and proper use of life-saving equipment and medication during medical emergencies.
Click to read the full article.

To define the procedure for verification and documentation of study drug dispensing by the pharmacist to ensure the correct investigational product (IP) or reference product is administered to each subject, in compliance with protocol and regulatory requirements.
Click to read the full article.

To define the procedure for determining, assigning, and verifying adequate staffing levels at clinical units involved in the conduct of BA/BE studies to ensure subject safety, compliance with protocol requirements, and uninterrupted trial operations.
Click to read the full article.

To define a standardized process for recording and reviewing safety data on a daily basis for all subjects enrolled in BA/BE studies to ensure real-time monitoring, timely intervention, and regulatory compliance.
Click to read the full article.

To define a systematic approach for handling subject withdrawals during BA/BE clinical trials, including documentation, notification, replacement strategies, and regulatory compliance to ensure study continuity and integrity.
Click to read the full article.